Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin in Bipolar II Depression
NCT04433845Phase 2Unknown
- Sponsor
- Sheppard Pratt
- Start
- Mar 2021
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in Bipolar II disorder (BP-II), major depressive disorder (MDD), sponsored by Sheppard Pratt. Status: unknown.
02
Drugs
psilocybin
03
Conditions
Bipolar II disorder (BP-II)major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04433845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04433845.